ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018


View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

Monday, 17.09.2018

07:00 - 08:15202CC3 Lung cancer: personalised treatment and palliative careChallenging clinical cases
07:00 - 08:15205CC4 TuberculosisChallenging clinical cases
07:00 - 08:15206CC5 Pulmonary vasculitis: the great chameleonChallenging clinical cases
08:30 - 10:30210Paediatric Grand RoundGrand round
08:30 - 10:30211State of the art session: Thoracic oncologySymposium
08:30 - 10:30212Therapeutic breakthroughs Year in ReviewYear in review
08:30 - 10:30213New trends in the management of difficult-to-wean patientsSymposium
08:30 - 10:30214Sleep apnoea: is it time for new therapies?Symposium
08:30 - 10:30215Rare lung diseasesSymposium
08:30 - 10:30216New modalities in asthma treatmentOral Presentation
08:30 - 10:30217Pulmonary embolism: what we need to knowHot topics
08:30 - 10:30218Cross-talk in the lung microenvironment: implications for chronic lung diseaseSymposium
08:30 - 10:30219COPD and chronic respiratory disease: from misclassification to radiological findingsOral Presentation
08:30 - 10:30220Novel drug targets for asthma and COPDOral Presentation
08:30 - 10:30221Occupational and environmental lung diseases: from early influences and novel exposures to preventative approachesOral Presentation
08:30 - 10:30222New developments in tuberculosisOral Presentation
08:30 - 10:30223Pleural diseases and pneumonia: what's new ?Poster Discussion
08:30 - 10:30224Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coachOral Presentation
08:30 - 10:30225Integrating pharmacological and non-pharmacological management in COPD: are we there yet?Poster Discussion
08:30 - 10:30226Clinical determinants and biomarkers of COPDPoster Discussion
08:30 - 10:30227Improving the outcomes of community-acquired pneumoniaPoster Discussion
08:30 - 10:30228Let’s interact and discuss the hot topics in pulmonary rehabilitationPoster Discussion
08:30 - 10:30229The many facets of respiratory nursingPoster Discussion
10:45 - 12:45237Clinical Year in ReviewYear in review
10:45 - 12:45238State of the art session: Respiratory infectionsSymposium
10:45 - 12:45239Infectious agents and childhood asthmaSymposium
10:45 - 12:45240Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid doseHot topics
10:45 - 12:45241Integrated care for patients with pulmonary vascular disease, lung diseases and heart failureSymposium
10:45 - 12:45242Respiratory medicine meets hematologySymposium
10:45 - 12:45243Intercellular communication in tissue remodellingOral Presentation
10:45 - 12:45244COPD: from LABA/ICS to LABA/LAMA/ICSOral Presentation
10:45 - 12:45245Cell-matrix interactions in lung disease and regenerationSymposium
10:45 - 12:45246New predictors of morbidity and mortality in COPDOral Presentation
10:45 - 12:45247Respiratory muscles and lung function: from healthy subjects to patientsOral Presentation
10:45 - 12:45248Granulomatous disorders: epidemiology, genotype and phenotypeOral Presentation
10:45 - 12:45249Interventional pulmonology highlights in 2018: latest innovationsOral Presentation
10:45 - 12:45250New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseasesPoster Discussion
10:45 - 12:45251Multiomics studies in epidemiology: what can they tell us?Oral Presentation
10:45 - 12:45252The world of idiopathic pulmonary fibrosis (IPF): global registriesPoster Discussion
10:45 - 12:45253Lung cancer: personalised medicinePoster Discussion
10:45 - 12:45254New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and childrenPoster Discussion
10:45 - 12:45255New diagnostic tools for sleep and breathing and healthcare provision optionsPoster Discussion
10:45 - 12:45256Respiratory epidemiology: from COPD to factors that associate with lung function and infectionsPoster Discussion
12:50 - 14:40262Critically ill patients: prognostic factors and biomarkersThematic Poster
12:50 - 14:40263Preclinical and clinical studies of critical illnessThematic Poster
12:50 - 14:40264Muscles and diaphragm, and quality improvementThematic Poster
12:50 - 14:40265Non-invasive ventilation for acute respiratory failureThematic Poster
12:50 - 14:40266Non-invasive ventilation in chronic respiratory failureThematic Poster
12:50 - 14:40267New tools for managing respiratory failureThematic Poster
12:50 - 14:40268New methods and concepts in tests of lung and respiratory muscle functionThematic Poster
12:50 - 14:40269The value of lung function testing in various pathophysiological conditionsThematic Poster
12:50 - 14:40270Cardiopulmonary exercise testing in COPD and cardiovascular diseasesThematic Poster
12:50 - 14:40271New methods and concepts in exercise testingThematic Poster
12:50 - 14:40272From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)Thematic Poster
12:50 - 14:40273Diagnostics including questionnairesThematic Poster
12:50 - 14:40274Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep qualityThematic Poster
12:50 - 14:40275Obesity: comorbiditiesThematic Poster
12:50 - 14:40276Pleural effusions, infections and tumoursThematic Poster
12:50 - 14:40277Moving lung transplantation forwardThematic Poster
12:50 - 14:40278Predicting the future: biomarkers of respiratory infectionThematic Poster
12:50 - 14:40279Pneumonia: from the community to the intensive care unitThematic Poster
12:50 - 14:40280Mechanisms of respiratory infectionThematic Poster
12:50 - 14:40281Improving the quality of life of patients with bronchiectasisThematic Poster
12:50 - 14:40282Challenges in tuberculosis careThematic Poster
12:50 - 14:40283Tuberculosis comorbiditiesThematic Poster
12:50 - 14:40284Groups who are susceptible to tuberculosis: children, pregnant women and elderly peopleThematic Poster
12:50 - 14:40285Pulmonary tuberculosis: long term complications, rehabilitation and challengesThematic Poster
12:50 - 14:40286Lung cancer: new tools for diagnosis and patient assessmentThematic Poster
12:50 - 14:40287Lung cancer: novel prognostic markers and scoresThematic Poster
12:50 - 14:40288Lung cancer: modern therapies and beyondThematic Poster
12:50 - 14:40289Lung cancer: risk factors, supportive measures and quality improvementThematic Poster
12:50 - 14:40290Lung cancer: from the bench to the bedsideThematic Poster
12:50 - 14:40291Mesothelioma and pleural malignancy: investigations and managementThematic Poster
12:50 - 14:40292Clinical management of pleural malignancies, including mesotheliomaThematic Poster
12:50 - 14:40293Consequences of idiopathic interstitial pneumoniasThematic Poster
12:50 - 14:40294News on the diagnosis of idiopathic interstitial pneumoniaThematic Poster
12:50 - 14:40295Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)Thematic Poster
12:50 - 14:40296CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markersThematic Poster
12:50 - 14:40297Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatmentThematic Poster
12:50 - 14:40298Granulomatous disorders: heterogeneous diseases with variable managementThematic Poster
12:50 - 14:40299Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)Thematic Poster
12:50 - 14:40300Pulmonary hypertension: therapyThematic Poster
12:50 - 14:40301Experimental research in pulmonary hypertensionThematic Poster
12:50 - 14:40302Clinical aspects of pulmonary hypertensionThematic Poster
12:50 - 14:40303Pulmonary hypertension in lung diseases and the role of the right ventricleThematic Poster
12:50 - 14:40304Diagnosis, prognostication and treatment of pulmonary embolismThematic Poster
12:50 - 14:40305Medical education via the web and the internetThematic Poster
12:50 - 14:40306COPD, asthma and tuberculosis: benefits related to therapy costsThematic Poster
13:00 - 14:30307New biologics for asthma: which patients, which agents, which results, at what cost?Lunchtime session
13:00 - 14:15314Paediatric Respiratory DiseasesLungs on fire
13:00 - 14:00315ME7 Monitoring of home mechanical ventilation in neuromuscular disordersMeet the expert
13:00 - 14:30316PF Occupational lung disease – professional and patient perspectivesPatient forum
13:00 - 14:00317ME8 Diagnosing bronchiectasis and cystic fibrosisMeet the expert
13:00 - 14:00319ME5 Lung cancer screeningMeet the expert
14:45 - 16:45333Chronic pulmonary aspergillosis: from guidelines to real-life implementationHot topics
14:45 - 16:45334Imaging chronic lung diseases: moving from structure to functionSymposium
14:45 - 16:45335Idiopathic pulmonary fibrosis diagnosis: new guidelinesGuidelines session
14:45 - 16:45336Advances in community-acquired pneumonia managementSymposium
14:45 - 16:45337Roles of innate lymphoid cells in asthmaHot topics
14:45 - 16:45338Microbiomes in respiratory diseaseSymposium
14:45 - 16:45339New methods for diagnosing and treating lung diseasesOral Presentation
14:45 - 16:45340Molecular mechanisms and treatment of pulmonary hypertensionOral Presentation
14:45 - 16:45341The best of the European Respiratory Journal in 2018Symposium
14:45 - 16:45342Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxiaOral Presentation
14:45 - 16:45343Ventilation and lung imaging in critically ill patientsOral Presentation
14:45 - 16:45344Lung cancer: new aspects in diagnosis and managementOral Presentation
14:45 - 16:45345Recent insights in childhood asthma and wheezingOral Presentation
14:45 - 16:45346Pulmonary hypertension: right ventricle function, haemodynamics and exercisePoster Discussion
14:45 - 16:45347Lung transplant science: from primary graft to chronic allograft dysfunctionOral Presentation
14:45 - 16:45348What’s new in lung function and exercise assessment in COPD?Poster Discussion
14:45 - 16:45349Exercise is medicine: testing and treating patients with some effortPoster Discussion
14:45 - 16:45350Cryobiopsy in interstitial lung disease (ILD)Poster Discussion
14:45 - 16:45351Innovations in equipment and their applicationPoster Discussion
14:45 - 16:45352Latest developments in cystic fibrosisPoster Discussion